Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-Analysis
posted on 2022-01-17, 10:10authored byAdis Journals on Behalf of, Edurne Arriola, Maria Gonzalez Cao, Manuel Domine, Javier De Castro, Manuel Cobo, Reyes Bernabé, Alejandro Navarro, Ivana Sullivan, José Trigo, Joaquín Mosquera, Leonardo Crama, Dolores Isla
Article full
text
The above graphical abstract represents the opinions of
the authors. For a full list of declarations, including
funding and author disclosure statements, please see the full text online (see
“read the peer-reviewed publication” opposite).